Women with early stage breast cancer increasingly choose to treat the cancer and save their breast. Breast conservation therapy (BCT) starts with the surgical removal of cancerous tissue in a procedure known as lumpectomy. Lumpectomy is followed by daily sessions of radiation therapy to the whole breast for six weeks. Whole breast irradiation (WBI) is widely accepted as the “gold standard” for breast radiotherapy based on over three decades of experience. The BCT protocol also requires additional localized radiation, known as the “boost” dose, aimed only at the tissue surrounding the tumor bed. The combination of surgery and completion of radiation therapy has been effective in preventing cancer recurrence. Numerous studies show that women with early stage disease have a clear option to preserve the breast and fight off the cancer.
AccuBoost® is the latest innovation in breast radiotherapy that enables your radiation oncologist to achieve the goal of targeting the boost dose to the lumpectomy cavity margin – the tissue that is the most likely site of future recurrence. Treatment enabled by AccuBoost technology combines a noninvasive method of delivering a well focused beam with the power of real-time image guidance to target the radiation dose accurately and reliably to the surgical excision site (target tissue). Additionally, the AccuBoost process strongly limits unintentional exposure to otherwise healthy tissue and minimizes radiation-related side effects.
If you are interested in learning more about Tacoma Radiation Oncology Center or would simply like more information about our services, contact us and a member of our team will respond accordingly.
At Tacoma Valley Radiation Oncology Centers we’re passionate about our patients. Our caring and highly trained team will treat you like family while providing you with the most advanced treatment planning and sophisticated, cutting-edge radiation therapies with the highest level of quality and personalized care.